Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MU vs GSK✓SelectedUSD · GSKMU vs GSK performance historyLatest closeAs of-7.62%11/16
Stock and ETF performance explorer

MU vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+197.5%
GSK return
+9.7%
Excess return
+187.8%
Maximum drawdown
-45.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-7.6%-0.1%-7.5%-7.7%
7D-1.9%-1.3%-0.6%-2.4%
30D-18.2%+2.7%-20.9%-16.8%
3M-26.0%+2.7%-28.7%-24.4%
6M-0.7%+3.3%-4.1%+1.3%
YTD+152.1%+6.5%+145.6%+158.8%
All+197.5%+9.7%+187.8%+201.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling